PFKFB3 and neoplasm: The combination of cisplatin and PFKFB3 inhibition by PFK15 was more potent to inhibit tumor growth than each single treatment (Fig. 8a–c), suggesting a possible benefit of combining PFKFB3 inhibitors with cisplatin therapy (Fig. 8d).